文摘
A practical 9-step synthesis of the dual matrix metalloprotease/tumor necrosis factor inhibitor MMP090, trans-(R)-[[N-(4-ethoxyphenylsulfonyl)-N-(4-pyridinylmethyl)]amino]-N-hydroxy-4-propoxy cyclohexaneacetamide 10, was accomplished in 12%overall yield from D-4-hydroxyphenylglycine. Highlights include: (1) selective hydrogenation of D-hydroxyphenylglycineto afford predominantly the trans isomer without racemization;(2) virtually complete removal of the undesired cis diastereoisomer by fractional recrystallization of a TBS ether derivativeof the functionalized cyclohexylglycine; (3) direct conversionof the TBS ether into the n-propyl ether in the presence of acatalytic amount of bismuth bromide in high yield; and (4)conversion of the carboxylic acid into the hydroxamic acid usingan aqueous solution of hydroxylamine.